Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147

1.

Experience with Salmonella typhi Vi capsular polysaccharide vaccine.

Hessel L, Debois H, Fletcher M, Dumas R.

Eur J Clin Microbiol Infect Dis. 1999 Sep;18(9):609-20. Review.

PMID:
10534182
[PubMed - indexed for MEDLINE]
2.

Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines.

Tacket CO, Ferreccio C, Robbins JB, Tsai CM, Schulz D, Cadoz M, Goudeau A, Levine MM.

J Infect Dis. 1986 Aug;154(2):342-5. No abstract available.

PMID:
2425009
[PubMed - indexed for MEDLINE]
3.

Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report.

Acharya IL, Lowe CU, Thapa R, Gurubacharya VL, Shrestha MB, Cadoz M, Schulz D, Armand J, Bryla DA, Trollfors B, et al.

N Engl J Med. 1987 Oct 29;317(18):1101-4.

PMID:
3657877
[PubMed - indexed for MEDLINE]
4.

Immunogenicity of a new Salmonella Typhi Vi polysaccharide vaccine--vax-TyVi--in Cuban school children and teenagers.

Azze RF, Rodríguez JC, Iniesta MG, Marchena XR, Alfonso VM, Padrón FT.

Vaccine. 2003 Jun 20;21(21-22):2758-60.

PMID:
12798615
[PubMed - indexed for MEDLINE]
5.

Isotypes of human vaccinal antibodies to the Vi capsular polysaccharide of Salmonella typhi.

Brugier JC, Barra A, Schulz D, Preud'homme JL.

Int J Clin Lab Res. 1993;23(1):38-41.

PMID:
8477090
[PubMed - indexed for MEDLINE]
6.

Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.

Robbins JD, Robbins JB.

J Infect Dis. 1984 Sep;150(3):436-49. Review.

PMID:
6207249
[PubMed - indexed for MEDLINE]
7.

Immunogenicity of Vi capsular polysaccharide vaccine evaluated for three years in Korea.

Kim YR, Yoo JH, Hur JK, Kang JH, Shin WS, Kang MW.

J Korean Med Sci. 1995 Oct;10(5):314-7.

PMID:
8750055
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Immunological evaluation of Vi capsular polysaccharide of Salmonella enterica subsp. Typhi vaccine by serum bactericidal assay.

Ahmadi H, Tabaraie B, Maleknia S, Shapouri R, Nejati M, Pour Mirza Gholi F, Hedayati M, Sadati M, Zahednia S, Sharifat Salmani A.

J Med Microbiol. 2013 Feb;62(Pt 2):283-6. doi: 10.1099/jmm.0.047159-0. Epub 2012 Oct 25.

PMID:
23105026
[PubMed - indexed for MEDLINE]
9.

Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam.

Kossaczka Z, Lin FY, Ho VA, Thuy NT, Van Bay P, Thanh TC, Khiem HB, Trach DD, Karpas A, Hunt S, Bryla DA, Schneerson R, Robbins JB, Szu SC.

Infect Immun. 1999 Nov;67(11):5806-10.

PMID:
10531232
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

Lin FY, Ho VA, Khiem HB, Trach DD, Bay PV, Thanh TC, Kossaczka Z, Bryla DA, Shiloach J, Robbins JB, Schneerson R, Szu SC.

N Engl J Med. 2001 Apr 26;344(17):1263-9.

PMID:
11320385
[PubMed - indexed for MEDLINE]
Free Article
11.

Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trial.

Kantele A, Pakkanen SH, Karttunen R, Kantele JM.

PLoS One. 2013 Apr 8;8(4):e60583. doi: 10.1371/journal.pone.0060583. Print 2013.

PMID:
23593253
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Protective efficacy and immunogenicity of Vi-porin conjugate against Salmonella typhi.

Singh M, Ganguly NK, Kumar L, Vohra H.

Microbiol Immunol. 1999;43(6):535-42.

PMID:
10480549
[PubMed - indexed for MEDLINE]
13.

[Efficacy and side effects following immunization with Salmonella typhi Vi capsular polysaccharide vaccine].

Wang ZG, Zhou WZ, Shi J.

Zhonghua Liu Xing Bing Xue Za Zhi. 1997 Feb;18(1):26-9. Chinese.

PMID:
9812477
[PubMed - indexed for MEDLINE]
14.

Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.

Tacket CO, Pasetti MF, Sztein MB, Livio S, Levine MM.

J Infect Dis. 2004 Aug 1;190(3):565-70. Epub 2004 Jun 30.

PMID:
15243933
[PubMed - indexed for MEDLINE]
Free Article
15.

Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909.

Wang JY, Noriega FR, Galen JE, Barry E, Levine MM.

Infect Immun. 2000 Aug;68(8):4647-52.

PMID:
10899868
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever.

Tacket CO, Levine MM, Robbins JB.

Vaccine. 1988 Aug;6(4):307-8.

PMID:
3188615
[PubMed - indexed for MEDLINE]
17.

Typhoid Vi: a less reactogenic vaccine.

Cumberland NS, St Clair Roberts J, Arnold WS, Patel RK, Bowker CH.

J Int Med Res. 1992 Jun;20(3):247-53.

PMID:
1397669
[PubMed - indexed for MEDLINE]
18.

Comparison of the immunogenicity and safety of two different brands of Salmonella typhi Vi capsular polysaccharide vaccine.

Sabitha P, Prabha Adhikari MR, Chowdary A, Prabhu M, Soofi M, Shetty M, Kamath A, Lokaranjan SS, Bangera SS.

Indian J Med Sci. 2004 Apr;58(4):141-9.

PMID:
15122049
[PubMed - indexed for MEDLINE]
Free Article
19.

Persistence of antibodies to the Salmonella typhi Vi capsular polysaccharide vaccine in South African school children ten years after immunization.

Keddy KH, Klugman KP, Hansford CF, Blondeau C, Bouveret le Cam NN.

Vaccine. 1999 Jan;17(2):110-3.

PMID:
9987143
[PubMed - indexed for MEDLINE]
20.

[Conjugate vaccines against bacterial infections: typhoid fever].

Paniagua J, García JA, López CR, González CR, Isibasi A, Kumate J.

Salud Publica Mex. 1992 May-Jun;34(3):268-73. Spanish.

PMID:
1377407
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk